Search NASA⌕ Search

SEARCH · Search NASA

Results for “Phase 2”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9
All sourcesNASA NTRSDOE OSTI
DOE OSTI2014

Involved-Node Proton Therapy in Combined Modality Therapy for Hodgkin Lymphoma: Results of a Phase 2 Study

Purpose: This study describes the early clinical outcomes of a prospective phase 2 study of consolidative involved-node proton therapy (INPT) as a component of combined-mode therapy in patients with stages I to III Hodgkin lymphoma (HL) with mediastinal involvement. Methods and Materials: Between September 2009 and June 2013, 15 patients with newly diagnosed HL received INPT after completing chemotherapy in an institutional review board-approved protocol comparing the dosimetric impact of PT with those of three-dimensional conformal radiation therapy (3DCRT) and intensity modulated RT. Based on {sup 18}F-Fluorodeoxyglucose positron emission tomography/computed tomography ({sup 18}F-FDG PET/CT) response, 5 children received 15 to 25.5 cobalt Gy equivalent (CGE) of INPT after receiving 4 cycles of Adriamycin, Bleomycin, Vincristine, Etoposide, Prednisone, Cyclophosphamide or Vincristine, adriamycin, methotrexate, Prednisone chemotherapy, and 10 adults received 30.6 to 39.6 CGE of INPT after 3 to 6 cycles of Adriamycin, Bleomycine, Vinblastine, Dacarbazine. Patients were routinely evaluated for toxicity during and after treatment, using Common Terminology Criteria for Adverse Events, version 3.0, and for relapse by physical examination and routine imaging. Relapse-free survival (RFS) and event-free survival (EFS) rates were calculated using the Kaplan-Meier method from the time of diagnosis. Results: The median follow-up was 37 months (range, 26-55). Two events occurred during follow-up: 1 relapse (inside and outside the targeted field) and 1 transformation into a primary mediastinal large B cell lymphoma. The 3-year RFS rate was 93%, and the 3-year EFS rate was 87%. No acute or late grade 3 nonhematologic toxicities were observed. Conclusions: Although decades of follow-up will be needed to realize the likely benefit of PT in reducing the risk of radiation-induced late effects, PT following chemotherapy in patients with HL is well-tolerated, and disease outcomes were similar to those of conventional photon therapy.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2014

IDC Reengineering Phase 2 Risk List

This document contains the risk list for the IDC Reengineering Phase 2 project along with some background information related to the risk process.

42 ENGINEERING↗
DOE OSTI2010

Phase relations and hardness trends of ZrO[subscript 2] phases at high pressure

We use high-resolution synchrotron x-ray powder diffraction and density-functional theory (DFT) to investigate the phase stability, equations of state (EOSs), and mechanical hardness of zirconia (ZrO{sub 2}) up to {approx}54 and 160 GPa, respectively. For the equilibrium phase at ambient conditions (MI), we provide an experimental EOS that is comparable to results obtained from room-pressure Brillouin scattering experiments and bulk modulus-volume systematics but different from previous high-pressure experiments. The experimental second-order Birch-Murnaghan EOS parameters of MI-ZrO{sub 2} are: ambient-pressure volume (V{sub 0}) of 35.15({+-}0.03) {angstrom}{sup 3}/f.u. with an ambient-pressure bulk modulus K{sub 0} of 210({+-}28) GPa. For the high-pressure OI phase, we find that the K{sub 0} = 290({+-}11) GPa, which is 19%-32% higher than previously determined, and V{sub 0} = 33.65({+-}0.07) {angstrom}{sup 3}/f.u. The small volume decrease of 3.4% across the MI {yields} OI transition at {approx}10 GPa is associated with a 38% increase in the bulk modulus consistent with our DFT calculations that predict a {approx}36% and 39% increase in K{sub 0} for the generalized gradient and local density approximations, respectively. In contrast to the EOS of MI and OI, we find that our experimental EOS for the high-pressure OII phase is in good agreement with previous measurements. The large volume decrease across the OI {yields} OII phase transition as obtained from both our experiments and calculations is {approx}10%. Our estimates, using scaling relations, indicate that this phase, while dense and quenchable, may have a comparatively low mechanical hardness of {approx} 10 GPa.

43 PARTICLE ACCELERATORS↗
DOE OSTI2014

Phase 2 Study of Combined Sorafenib and Radiation Therapy in Patients With Advanced Hepatocellular Carcinoma

Purpose: This phase 2 study evaluated the efficacy of radiation therapy (RT) with concurrent and sequential sorafenib therapy in patients with unresectable hepatocellular carcinoma (HCC). Methods and Materials: Forty patients with unresectable HCC unfit for transarterial chemoembolization were treated with RT with concurrent and sequential sorafenib. Sorafenib was administered from the commencement of RT at a dose of 400 mg twice daily and continued to clinical or radiologic progression, unacceptable adverse events, or death. All patients had underlying Child-Pugh A cirrhosis. The maximal tumor diameter ranged from 3.0 cm to 15.5 cm. Coexisting portal vein thrombosis was found in 24 patients and was irradiated simultaneously. The cumulative RT dose ranged from 40 Gy to 60 Gy (median, 50 Gy). Image studies were done 1 month after RT and then every 3 months thereafter. Results: Thirty-three (83%) completed the allocated RT. During RT, the incidence of hand-foot skin reactions ≥ grade 2 and diarrhea were 37.5% and 25%, respectively, and 35% of patients had hepatic toxicities grade ≥2. Twenty-two (55.0%) patients achieved complete or partial remission at the initial assessment, and 18 (45%) had stable or progressive disease. The 2-year overall survival and infield progression-free survival (IFPS) were 32% and 39%, respectively. A Cancer of the Liver Italian Program (CLIP) score ≥2 was associated with an inferior outcome in overall survival. Six patients (15%) developed treatment-related hepatic toxicity grade ≥3 during the sequential phase, and 3 of them were fatal. Conclusions: When RT and sorafenib therapy were combined in patients with unresectable HCC, the initial complete or partial response rate was 55% with a 2-year IFPS of 39%. A CLIP score ≥2 was associated with an inferior outcome in overall survival. Hepatic toxicities are a major determinant of the safety; the combination should be used with caution and needs further investigation.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2014

IDC Reengineering Phase 2 Glossary

This document contains the glossary of terms used for the IDC Reengineering Phase 2 project. This version was created for Iteration I2.

96 KNOWLEDGE MANAGEMENT AND PRESERVATION↗
DOE OSTI2014

IDC Reengineering Phase 2 Glossary

This document contains the glossary of terms used for the IDC Reengineering Phase 2 project. This version was created for Iteration I1.

42 ENGINEERING↗
NASA NTRS1993

Lightweight solar concentrator structures, phase 2

This report summarizes the results of the program conducted by Ultramet under SBIR Phase 2 Contract NAS3-25418. The objective of this program was to develop lightweight materials and processes for advanced high accuracy Space Solar Concentrators using rigidized foam for the substrate structure with an integral optical surface.

Williams, Brian E.↗
DOE OSTI2015

Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China

Purpose: The aim of this prospective multi-institutional phase 2 study was to investigate disease control, survival outcomes, and toxicity after thoracic three-dimensional radiation therapy (3D-RT) with concurrent chemotherapy for newly diagnosed stage IV non-small cell lung cancer (NSCLC). Methods and Materials: Eligible patients were 18 to 80 years of age, had a Karnofsky performance status (KPS) score ≥70%, and newly diagnosed stage IV NSCLC with limited metastatic disease (defined as involving ≤3 organs). Patients received platinum-doublet chemotherapy with concurrent irradiation to the primary tumor. Primary endpoints were overall survival (OS) and acute toxicity. Results: From May 2008 to May 2012, 198 eligible patients were enrolled from 7 cancer centers. Most patients died with distant metastasis; only 10% died with isolated primary recurrence. Median OS time was 13.0 months (95% confidence interval [CI]: 11.7-14.3); OS rates were 53.5% at 1 year, 15.8% at 2 years, and 9.2% at 3 years. Median progression-free survival (PFS) time was 9.0 months (95% CI: 7.7-10.3); corresponding PFS rates were 30.8%, 8.2%, and 6.1%. The 1-year, 2-year, and 3-year local (primary tumor) control rates were 78.8%, 57.7%, and 55.4%. Multivariate analysis showed that delivery of ≥63 Gy to the primary tumor (P=.014), having a primary tumor volume <134 cm{sup 3} (P=.008), and having a stable or higher KPS score after treatment (P=.01) were independent predictors of better OS. The most common severe (grades 3-4) acute toxicities were hematologic: leukopenia (37.9%), thrombocytopenia (10.1%), and anemia (6.9%). No patients experienced grade 4 or 5 radiation-related toxicity; 2.5% had acute grade 3 pneumonitis, and 6.6% had acute grade 3 radiation esophagitis. Conclusions: Thoracic 3D-RT to the primary tumor with concurrent chemotherapy led to satisfactory survival outcomes with acceptable toxicity. Radiation dose, primary tumor volume, and PFS after treatment all predicted survival in these patients with limited-metastasis NSCLC.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2016

IDC Re-Engineering Phase 2 Glossary.

This document contains the glossary of terms used for the IDC Re-Engineering Phase 2 project. This version was created for Iteration E1.

42 ENGINEERING↗
DOE OSTI2016

IDC Re-Engineering Phase 2 Glossary

This document contains the glossary of terms used for the IDC Re-Engineering Phase 2 project. This version was created for Iteration E2.

97 MATHEMATICS AND COMPUTING↗
NASA NTRS1978

An investigation of wing buffeting response at subsonic and transonic speeds. Phase 2: F-111A flight data analysis. Volume 2: Plotted power spectra

Plotted power spectra for all of the flight points examined during the Phase 2 flight data analysis are presented. Detailed descriptions of the aircraft, the flight instrumentation and the analysis techniques are given. Measured and calculated vibration mode frequencies are also presented to assist in further interpretation of the PSD data.

Benepe, D. B.↗
NASA NTRS1991

Civil tiltrotor missions and applications. Phase 2: The commercial passenger market

The commercial passenger market for the civil tiltrotor was examined in phase 2. A market responsive commercial tiltrotor was found to be technically feasible, and a significant worldwide market potential was found to exist for such an aircraft, especially for relieving congestion in urban area-to-urban area service and for providing cost effective hub airport feeder service. Potential technical obstacles of community noise, vertiport area navigation, surveillance, and control, and the pilot/aircraft interface were determined to be surmountable. Nontechnical obstacles relating to national commitment and leadership and development of ground and air infrastructure were determined to be more difficult to resolve; an innovative public/private partnership is suggested to allow coordinated development of an initial commercial tiltrotor network to relieve congestion in the crowded US Northeast corridor by the year 2000.

Thompson, P.↗
NASA NTRS1994

SOFIA: Aircraft system, aft telescope cavity configuration, phase 2. Volume 1: Executive summary

This volume summarizes the tasks performed by E-Systems during Phase 2 of a study evaluating the structural modifications required to install the Stratospheric Observatory for Infrared Astronomy, SOFIA in the Boeing 747 airplane. An optimal structural modification concept for installation of the Infrared telescope is identified, and the concept is validated by analysis of the static and dynamic characteristics of the modified structure.

Source record↗
NASA NTRS2015

Regolith Advanced Surface Systems Operations Robot (RASSOR) Phase 2 and Smart Autonomous Sand-Swimming Excavator

The Regolith Advanced Surface Systems Operations Robot (RASSOR) Phase 2 is an excavation robot for mining regolith on a planet like Mars. The robot is programmed using the Robotic Operating System (ROS) and it also uses a physical simulation program called Gazebo. This internship focused on various functions of the program in order to make it a more professional and efficient robot. During the internship another project called the Smart Autonomous Sand-Swimming Excavator was worked on. This is a robot that is designed to dig through sand and extract sample material. The intern worked on programming the Sand-Swimming robot, and designing the electrical system to power and control the robot.

Regolith↗